
About KLOTHO Therapeutics
KLOTHO Therapeutics is a Healthcare company based in San Diego (United States) founded in 2016. Patent-pending klotho protein technology is developed for anti-aging applications. KLOTHO Therapeutics has raised $10 million across 1 funding round from investors including Thynk Capital. KLOTHO Therapeutics offers products and services including Human Klotho Protein. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics.
Company details
Klotho Therapeutics was founded in 2016 in San Diego, United States, within the biotechnology sector. Technology mimicking the human Klotho protein, a single-pass membrane protein, is developed to address aging-related conditions. Longevity is promoted, while onset of dementia, kidney disease, diabetes, and cancer is delayed through this approach. Operations focus on patent-pending innovations for therapeutic applications.
- Headquarters San Diego, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website klotho.com
- Social LinkedIn X Facebook YouTube
- Total Equity Funding$10M (USD)
in 1 rounds
- Latest Funding Round$10M (USD), Series A
Nov 2017
- Investors
Products & Services of KLOTHO Therapeutics
KLOTHO Therapeutics offers a comprehensive portfolio of products and services, including Human Klotho Protein.
Patented protein that delays aging-related diseases like cognitive decline.
Apps and channels of KLOTHO Therapeutics
its YouTube channel Klotho Marketing has 61 subscribers and 3 videos.
Videos from KLOTHO Therapeutics
The most watched videos on KLOTHO Therapeutics's YouTube channel, Klotho Marketing (61 subscribers). Click a video to play it here.
More on Klotho Marketing.
Funding Insights of KLOTHO Therapeutics
KLOTHO Therapeutics has successfully raised a total of $10M through 1 strategic funding round. The most recent funding activity was a Series A round of $10 million completed in November 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10M
- Total Rounds 1
- Last Round Series A β $10M
- First Round $10M
(Nov 2017)
- Investors Count 1
All 1 funding rounds of KLOTHO Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2017 | $10M | Series A | β | Thynk Capital | β |
1 investors in total: 1 institutional.
Investors in KLOTHO Therapeutics
KLOTHO Therapeutics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Thynk Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage tech & life sciences focused VC firm funding companies in South Africa | thynkcapital.com | San Diego, United States |
Investor details for KLOTHO Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of KLOTHO Therapeutics
1 people are tracked at KLOTHO Therapeutics (1 in leadership).
| Name | Role | Group |
|---|---|---|
James Plante | Founder, Chief Executive Officer & Chairman | Leadership |
Complete people profiles for KLOTHO Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of KLOTHO Therapeutics
2 dated milestones of KLOTHO Therapeutics across 1 years, from founding to its latest funding, stage changes and deals.
- Founded KLOTHO Therapeutics is founded.
- Funding First funding round of $10.0M.
Web traffic of KLOTHO Therapeutics
The website of KLOTHO Therapeutics (klotho.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▲ 50.7% vs previous month
Websites whose visitors overlap most with KLOTHO Therapeutics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
buckylabs.com | buckylabs.com | 100% | #4,178,344 | β |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as KLOTHO Therapeutics (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Klotho Therapeutics
Complete news archive for KLOTHO Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about KLOTHO Therapeutics
KLOTHO Therapeutics was founded in 2016 and raised its 1st funding round 1 year after it was founded.
KLOTHO Therapeutics is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
KLOTHO Therapeutics is a funded company, having raised a total of $10M across 1 funding round to date. The company's 1st funding round was a Series A of $10M, raised on Nov 2017.
Klotho Therapeutics was founded in 2016 in San Diego, United States, within the biotechnology sector. Technology mimicking the human Klotho protein, a single-pass membrane protein, is developed to address aging-related conditions. Longevity is promoted, while onset of dementia, kidney disease, diabetes, and cancer is delayed through this approach. Operations focus on patent-pending innovations for therapeutic applications.
KLOTHO Therapeutics offers Human Klotho Protein.
KLOTHO Therapeutics has 1 investor. Key investors include Thynk Capital.
